Solmaz Shirjang

3.2k citations
18 papers · 2.4k indexed · 1 hit paper · h-index 16
Topics
MicroRNA in disease regulation (9 papers)Circular RNAs in diseases (6 papers)Cancer-related molecular mechanisms research (6 papers)
Partner nations
IranDenmarkAustralia

In The Last Decade

Solmaz Shirjang

17 papers receiving 2.4k citations

Hit Papers

The Different Mechanisms of Cancer Drug Resistance: A Bri...201720262020202320174008001.2k

Peers

Solmaz Shirjang
Comparison fields: 5 of 118
  • Molecular Biology 1.5k
  • Cancer Research 823
  • Oncology 498
  • Biomedical Engineering 227
  • Biomaterials 223
Replace Mateusz Kciuk with:
Mateusz Kciuk Poland
Sadaf Davudian Iran
Maliheh Entezari Iran
Ansar Karimian Iran
Dimakatso Alice Senthebane South Africa
Reza Bayat Mokhtari Canada
Cristina P. R. Xavier Portugal
Genevieve Housman United States
Mohsen Rashidi Iran
Chern Ein Oon Malaysia
Solmaz Shirjang relative to Mateusz Kciuk Poland Mateusz Kciuk's profile →
Citations per field
00.5×10×14.0×
Mateusz Kciuk · 1×
Citations per year

Countries citing papers authored by Solmaz Shirjang

Since Specialization
Citations

This map shows the geographic impact of Solmaz Shirjang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Solmaz Shirjang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Solmaz Shirjang more than expected).

Fields of papers citing papers by Solmaz Shirjang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Solmaz Shirjang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Solmaz Shirjang. The network helps show where Solmaz Shirjang may publish in the future.

Co-authorship network of co-authors of Solmaz Shirjang

This figure shows the co-authorship network connecting the top 25 collaborators of Solmaz Shirjang. A scholar is included among the top collaborators of Solmaz Shirjang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Solmaz Shirjang. Solmaz Shirjang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 0
2 159
3 80
4 53
5 23
6 42
7 37
8 134
9 97
10 12
11 51
12 39
13
The Different Mechanisms of Cancer Drug Resistance: A Brief Reviewbreakdown →
1384
14 35
15 84
16 33
17 54
18
Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
63

About Solmaz Shirjang

Solmaz Shirjang is a scholar working on Cancer Research, Complementary and alternative medicine and Molecular Biology, having authored 18 papers that have together received 2.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (823 citations), Drug Discovery (4 citations) and Molecular Biology (1.5k citations). Solmaz Shirjang has collaborated with scholars based in Iran, Denmark and Australia. Frequent co-authors include Behzad Mansoori, Ali Mohammadi, Behzad Baradaran, Sadaf Davudian, Pascal H. G. Duijf, Morten F. Gjerstorff, Behzad Baradaran, Tohid Kazemi, Souzan Najafi and Samira Asghari. Their work appears in journals such as Free Radical Biology and Medicine, Life Sciences and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026